Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Short Interest Down 46.5% in March

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the recipient of a large decrease in short interest in the month of March. As of March 13th, there was short interest totaling 3,890 shares, a decrease of 46.5% from the February 26th total of 7,265 shares. Based on an average daily volume of 71,236 shares, the short-interest ratio is currently 0.1 days.

Cardio Diagnostics Stock Performance

NASDAQ:CDIOW opened at $0.02 on Friday. The firm’s 50-day moving average is $0.02 and its 200-day moving average is $0.02. Cardio Diagnostics has a 52-week low of $0.01 and a 52-week high of $0.07.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc was founded in 2017 and is headquartered in Chicago, Illinois.